Genedata Biopharma Platform – 早期の開発適性評価へ向けた統合データ基盤

Early detection of developability risks is critical to avoid late‑stage surprises. Genedata enables teams to standardize, connect, and continuously assess developability data across assays and programs — capturing complete, structured evidence that supports advanced analytics and reliable AI‑based risk assessment and predictions. This enables objective candidate comparison as programs advance.